Immunomedics Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • Immunomedics's estimated annual revenue is currently $34.6M per year.(i)
  • Immunomedics received $125.0M in venture funding in May 2017.
  • Immunomedics's estimated revenue per employee is $288,042
  • Immunomedics's total funding is $30M.

Employee Data

  • Immunomedics has 120 Employees.(i)
  • Immunomedics grew their employee count by -8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.

keywords:Biotechnology,Cleantech,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Immunomedics News

2022-04-20 - Gilead Takes $2.7 Billion Writedown; Covid Drug Tops ...

Gilead raised eyebrows in 2020 when it agreed to buy Immunomedics for about $21 billion, a substantial premium for a company that was...

2022-04-13 - Gilead's Immunomedics floats $4M to put ASCO data fiasco to ...

Under a proposed settlement, Gilead Sciences' Immunomedics would shell out $4 million to resolve a lawsuit alleging it violated securities laws...

2022-04-06 - Immunomedics Investors Seek First Nod for $4 Million ...

Immunomedics Inc. investors who say the company misled them about cancer drug data presentations asked a federal judge in New Jersey for...

2019-09-12 - Immunomedics (IMMU) Looks Good: Stock Adds 6.1% in ...

Immunomedics, Inc. IMMU was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid ...

2019-09-12 - Immunomedics to Host Investor Event and Webcast on ...

12, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Immunomedics Funding

DateAmountRoundLead InvestorsReference
2015-02-09$96.4MUndisclosedGoldman, Sachs & Co.Article